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Abstract
Fragranced consumer products, such as cleaning supplies, air fresheners, and personal care products, can emit a range of air
pollutants and trigger adverse health effects. This study investigates the prevalence and types of effects of fragranced products on
asthmatics in the American population. Using a nationally representative sample (n = 1137), data were collected with an on-line
survey of adults in the USA, of which 26.8% responded as being medically diagnosed with asthma or an asthma-like condition.
Results indicate that 64.3% of asthmatics report one or more types of adverse health effects from fragranced products, including
respiratory problems (43.3%), migraine headaches (28.2%), and asthma attacks (27.9%). Overall, asthmatics were more likely to
experience adverse health effects from fragranced products than non-asthmatics (prevalence odds ratio [POR] 5.76; 95% con-
fidence interval [CI] 4.34–7.64). In particular, 41.0% of asthmatics report health problems from air fresheners or deodorizers,
28.9% from scented laundry products coming from a dryer vent, 42.3% from being in a room cleaned with scented products, and
46.2% from being near someone wearing a fragranced product. Of these effects, 62.8% would be considered disabling under the
definition of the Americans with Disabilities Act. Yet 99.3% of asthmatics are exposed to fragranced products at least once a
week. Also, 36.7% cannot use a public restroom if it has an air freshener or deodorizer, and 39.7%would enter a business but then
leave as quickly as possible due to air fresheners or some fragranced product. Further, 35.4% of asthmatics have lost workdays or
a job, in the past year, due to fragranced product exposure in the workplace. More than twice as many asthmatics would prefer
that workplaces, health care facilities and health care professionals, hotels, and airplanes were fragrance-free rather than
fragranced. Results from this study point to relatively simple and cost-effective ways to reduce exposure to air pollutants and
health risks for asthmatics by reducing their exposure to fragranced products.
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Semi-volatile organic compounds
Introduction
Fragranced consumer products pervade society and emit nu-
merous volatile organic compounds, such as limonene, alpha-
pinene, beta-pinene, acetaldehyde, and formaldehyde
(Steinemann 2015; Nazaroff and Weschler 2004), and semi-
volatile organic compounds, such as musks and phthalates
(Weschler 2009; Just et al. 2010). However, ingredients in
fragranced products are exempt from full disclosure on prod-
uct labels or safety data sheets (Steinemann 2015), limiting
awareness of potential emissions and exposures. Fragranced
products have been associated with a range of adverse health
effects including work-related asthma (Weinberg et al. 2017),
asthmatic exacerbations (Kumar et al. 1995; Millqvist and
Löwhagen 1996), respiratory difficulties (Caress and
Steinemann 2009), mucosal symptoms (Elberling et al.
2005), migraine headaches (Kelman 2004), and contact der-
matitis (Rastogi et al. 2007; Johansen 2003), as well as neu-
rological, cardiovascular, cognitive, musculoskeletal, and im-
mune system problems (Steinemann 2016).
This article investigates specifically the effects of exposure
to fragranced products on asthmatics in the US population. In
addition to health impacts, it also investigates societal access,
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preferences for fragrance-free environments, awareness of
fragranced product emissions, and implications for air quality
and health. It compares results from the sub-population of
asthmatics with non-asthmatics, as well as with the general
US population, as reported in Steinemann (2016). The study
provides important data on the extent and severity of the prob-
lem, pointing to opportunities to reduce the adverse health,
economic, and societal effects by reducing exposure to
fragranced products.
Methods
A nationally representative on-line survey was conducted of the
US population, representative of age, gender, and region (n =
1137, confidence limit = 95%, confidence interval = 3%). The
survey drew upon a large web-based US panel (over 5,000,000
people) held by Survey Sampling International, using random-
ized participant recruitment (SSI 2016). The survey instrument
was developed and tested over a two-year period before full
implementation in June 2016. The survey response rate was
95% (responses to panel recruitment 1201; screen-outs 13;
drop-outs 46; completes 1137), and all responses were anony-
mous. The research study received ethics approval from the
University of Melbourne. Details on the survey methodology
are provided as a supplemental document.
This article extends and deepens the general population
study of Steinemann (2016) by analyzing specifically the ef-
fects on asthmatics and compared to non-asthmatics and the
general population. Of the general population surveyed,
26.8% responded as being medically diagnosed with either
asthma (15.2%, n = 173) or an asthma-like condition
(12.5%, n = 142) or both (26.8%, n = 305). For the purposes
of the article, the sub-population of Basthmatics^ will be those
medically diagnosed with asthma, an asthma-like condition,
or both; the sub-population of Bnon-asthmatics^ will be those
in the general population other than asthmatics.
Survey questions investigated use and exposure to
fragranced products, both from one’s own use and from
others’ use, exposure contexts and products, health effects
related to exposures, impacts of fragrance exposure in the
workplace and in society, awareness of fragranced product
ingredients and labeling, preferences for fragrance-free envi-
ronments and policies, and demographic information.
Specific exposure contexts included air fresheners or de-
odorizers used in public restrooms and other environments,
scented laundry products coming from a dryer vent, being in
a room after it was cleaned with scented cleaning products,
being near someone wearing a fragranced product, entering a
business with the scent of fragranced products, fragranced
soap used in public restrooms, and ability to access environ-
ments that used fragranced products.
Fragranced products were categorized as follows: (a) air
fresheners and deodorizers (e.g., sprays, solids, oils, disks);
(b) personal care products (e.g., soaps, hand sanitizer, lotions,
deodorant, sunscreen, shampoos); (c) cleaning supplies (e.g.,
all-purpose cleaners, disinfectants, dishwashing soap); (d)
laundry products (e.g., detergents, fabric softeners, dryer
sheets); (e) household products (e.g., scented candles, rest-
room paper, trash bags, baby products); (f) fragrance (e.g.,
perfume, cologne, after-shave); and (g) other.
Health effects were categorized as follows: (a) migraine
headaches; (b) asthma attacks; (c) neurological problems
(e.g., dizziness, seizures, head pain, fainting, loss of coordina-
tion); (d) respiratory problems (e.g., difficulty breathing,
coughing, shortness of breath); (e) skin problems (e.g., rashes,
hives, red skin, tingling skin, dermatitis); (f) cognitive prob-
lems (e.g., difficulties thinking, concentrating, or remember-
ing); (g) mucosal symptoms (e.g., watery or red eyes, nasal
congestion, sneezing); (h) immune system problems (e.g.,
swollen lymph glands, fever, fatigue); (i) gastrointestinal
problems (e.g., nausea, bloating, cramping, diarrhea); (j) car-
diovascular problems (e.g., fast or irregular heartbeat, jitteri-
ness, chest discomfort); (k) musculoskeletal problems (e.g.,
muscle or joint pain, cramps, weakness); and (j) other.
Categories were derived from prior studies of fragranced prod-
ucts and health effects (Caress and Steinemann 2009; Miller
and Prihoda 1999) and pre-tested before full survey
implementation.
Results
Main findings are presented in this section, and full results for
asthmatics, non-asthmatics, and the general population are
provided as supplemental documentation. Demographic infor-
mation is provided in Table 1.
Fragranced product exposure
Among asthmatics, 99.0% are exposed to fragranced products
at least once a week, from their own use (71.1% air fresheners
and deodorizers; 85.9% personal care products; 78.4%
cleaning supplies; 81.3% laundry products; 76.7% household
products; 67.5% fragrance; 3.6% other). Further, 94.8% are
exposed to fragranced products at least once a week, from
others’ use. Combined, 99.3% of asthmatics are exposed to
fragranced products through their own use, others’ use, or
both. Among non-asthmatics, 98.1% are exposed to
fragranced products at least once a week from their own use,
91.1% from others’ use, and 98.9% from either or both. Thus,
asthmatics are more likely to be exposed to fragranced prod-
ucts, from their own use and others’ use and both, than non-
asthmatics (POR, 1.66; 95% CI, 0.36–7.71).
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Adverse health effects
Among asthmatics, 64.3% reported one or more types of adverse
health effects from exposure to one or more types of fragranced
products (43.3% respiratory problems; 27.2% mucosal symp-
toms; 28.2% migraine headaches; 19.0% skin problems; 27.9%
asthma attacks; 15.1% neurological problems; 14.1% cognitive
problems; 12.1% gastrointestinal problems; 9.8% cardiovascular
problems; 11.1% immune system problems; 9.5% musculoskel-
etal problems; and 1.3% other). Among non-asthmatics, 23.8%
reported one or more types of adverse health effects from expo-
sure to one or more types of fragranced products (see Table 2).
Thus, among all types of health effects (excepting asthma at-
tacks), asthmatics are more likely to be affected than non-
asthmatics (POR 5.76; 95% CI, 4.34–7.64).
Of the 64.3% of asthmatics reporting adverse health effects
from fragranced products, proportionately more males report
adverse effects than females, relative to non-asthmatics (asth-
matic 52.0% female, 48.0% male; non-asthmatic 60.1% fe-
male, 39.9% male) (POR 1.39; 95% CI, 0.93–2.97) (see
Table 3). Among all age groups, proportionately more asth-
matics in age group 25–34 report adverse effects relative to
non-asthmatics (asthmatic 69.7%; non-asthmatic 23.3%)
(POR 7.59; 95% CI, 4.19–13.76). Among all gender and
age groups, proportionately more males age 25–34 report ad-
verse effects relative to non-asthmatics (asthmatic 83.3%;
non-asthmatic 18.1%) (POR 22.65; 95% CI, 8.15–62.92).
Specific exposure contexts
Air fresheners and deodorizers were associated with health
problems for 41.0% of asthmatics (54.4% respiratory prob-
lems, 39.2% asthma attacks, 29.6% mucosal symptoms,
36.8% migraine headaches, 15.2% neurological problems,
Table 1 Demographic
information Asthmatics Non-asthmatics General
population
N N N
% of column
total
N
% of general
population row
N
% of column
total
% of column
total
% of general
population row
Total 305 305 832 832 1137
100.0% 26.8% 100.0% 73.2% 100.0%
Male/female
All males 136 136 389 389 525
44.6% 25.9% 46.8% 74.1% 46.2%
All females 169 169 443 443 612
55.4% 27.6% 53.2% 72.4% 53.8%
Gender–age
Male 18–24 16 16 31 31 47
5.2% 34.0% 3.7% 66.0% 4.1%
Male 25–34 36 36 94 94 130
11.8% 27.7% 11.3% 72.3% 11.4%
Male 35–44 42 42 94 94 136
13.8% 30.9% 11.3% 69.1% 12.0%
Male 45–54 30 30 78 78 108
9.8% 27.8% 9.4% 72.2% 9.5%
Male 55–65 12 12 92 92 104
3.9% 11.5% 11.1% 88.5% 9.1%
Female 18–24 26 26 52 52 78
8.5% 33.3% 6.3% 66.7% 6.9%
Female 25–34 40 40 95 95 135
13.1% 29.6% 11.4% 70.4% 11.9%
Female 35–44 43 43 112 112 155
14.1% 27.7% 13.5% 72.3% 13.6%
Female 45–54 41 41 103 103 144
13.4% 28.5% 12.4% 71.5% 12.7%
Female 55–65 19 19 81 81 100
6.2% 19.0% 9.7% 81.0% 8.8%
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26.4% skin problems, and others), and for 12.9% of non-
asthmatics (see Table 4). Thus, asthmatics were more likely
to experience adverse effects from air fresheners than non-
asthmatics (POR 4.71; 95% CI, 3.47–6.39).
Scented laundry products coming from a dryer vent were
associated with health problems for 28.9% of asthmatics
(38.6% respiratory problems, 30.7% asthma attacks, 30.7%
mucosal symptoms, 27.3% migraine headaches, 18.2% neu-
rological problems, 25.0% skin problems, and others), and for
6.5% of non-asthmatics (see Table 4). Thus, asthmatics were
more likely to experience adverse effects from scented laundry
products coming from a dryer vent than non-asthmatics (POR
5.84; 95% CI, 4.03–8.46).
Being in a room after it has been cleaned with scented
products was associated with health problems for 42.3% of
asthmatics (51.9% respiratory problems, 32.6% asthma at-
tacks, 27.1% mucosal symptoms, 32.6% migraine headaches,
21.7% neurological problems, 19.4% skin problems, and
others), and for 11.4% of non-asthmatics (see Table 4). Thus,
asthmatics were more likely to experience adverse effects from
being in a room after it has been cleaned with scented products
than non-asthmatics (POR 5.69; 95% CI, 4.16–7.77).
Being near someone wearing a fragranced product was
associated with health problems for 46.2% of asthmatics
(54.6% respiratory problems, 29.1% asthma attacks, 28.4%
mucosal symptoms, 31.9% migraine headaches, 19.1% neu-
rological problems, 17.0% skin problems, and others), and
15.3% of non-asthmatics (see Table 4). Thus, asthmatics were
more likely to experience adverse effects from being near
someone wearing a fragranced product than non-asthmatics
(POR 4.77; 95% CI, 3.56–6.40).
Exposure to fragranced products can trigger disabling
health effects, according to criteria from the Americans with
Disabilities Act (ADA 1990): "Do any of these health prob-
lems substantially limit one or more major life activities, such
as seeing, hearing, eating, sleeping, walking, standing, lifting,
bending, speaking, breathing, learning, reading, concentrating,
thinking, communicating, or working, for you personally?"
Among asthmatics reporting health problems, 62.8% reported
that the severity of the health effect from fragranced product
exposure was potentially disabling. Thus, asthmatics were
more likely to report disabling health effects from fragranced
products than non-asthmatics (POR 7.13; 95% CI, 5.11–9.95).
Ingredient disclosure and product claims
Among asthmatics, 41.3%were not aware that a Bfragrance^ in
a product is typically a chemical mixture of several dozen to
several hundred chemicals, 57.4% were not aware that fra-
grance chemicals do not need to be fully disclosed on the prod-
uct label or material safety data sheet, and 58.0% were not
aware that fragranced products typically emit hazardous air
pollutants such as formaldehyde. Further, 64.3% of asthmatics,
and 75.7% of non-asthmatics, were not aware that even so-
called natural, green, and organic fragranced products typically
emit hazardous air pollutants (28.9% of asthmatics and 15.7%
of non-asthmatics were aware). However, 60.3% of asthmatics,
and 60.1% of non-asthmatics, would not still use a fragranced
product if they knew it emitted hazardous air pollutants.
Societal and workplace effects
Fragranced products can also present barriers for asthmatics in
public places and the workplace. Among asthmatics, 36.7%
are prevented from using the restrooms in a public place,
because of the presence of an air freshener, deodorizer, or
scented product. Also, 28.9% are prevented from washing
their hands with soap in a public place, if the soap is
fragranced. Further, 43.9% are prevented from going to some
place because they would be exposed to a fragranced product
Table 2 Frequency and types of adverse health effects reported from
exposure to fragranced consumer products
Asthmatics Non-asthmatics General
population
305 832 1137
26.8% 73.2% 100.0%
Migraine headaches 86 93 179
28.2% 11.2% 15.7%
Asthma attacks 85 6 91
27.9% 0.7% 8.0%
Neurological problems 46 36 82
15.1% 4.3% 7.2%
Respiratory problems 132 79 211
43.3% 9.5% 18.6%
Skin problems 58 63 121
19.0% 7.6% 10.6%
Cognitive problems 43 23 66
14.1% 2.8% 5.8%
Mucosal symptoms 83 101 184
27.2% 12.1% 16.2%
Immune system
problems
34 11 45
11.1% 1.3% 4.0%
Gastrointestinal
problems
37 26 63
12.1% 3.1% 5.5%
Cardiovascular
problems
30 20 50
9.8% 2.4% 4.4%
Musculoskeletal
problems
29 14 43
9.5% 1.7% 3.8%
Other 4 15 19
1.3% 1.8% 1.7%
Total 196 198 394
(One or more health
problems)
64.3% 23.8% 34.7%
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that would make them sick. Notably, 39.7% report that if they
enter a business, and smell air fresheners or some fragranced
product, they want to leave as quickly as possible.
Significantly, 35.4% of asthmatics, and 7.7% of non-asth-
matics, have become sick, lost workdays, or lost a job, in the
past 12 months, due to fragranced products in their work en-
vironment. Thus, asthmatics were more likely to have lost
workdays or lost a job due to illness from fragranced products
in their work environment than non-asthmatics (POR 6.58;
95% CI, 4.65–9.30).
Fragrance-free policies receive a strong majority of support.
Among asthmatics, 66.2%would be supportive of a fragrance-
free policy in the workplace (compared to 16.1% that would
not). Thus, more than four times as many asthmatics would
prefer a fragrance-free workplace than fragranced. Also,
72.1% of asthmatics would prefer that health care facilities
and health care professionals be fragrance-free (compared to
14.8% that would not). Thus, nearly five times as many asth-
matics would prefer fragrance-free health care facilities and
professionals than fragranced.
Among non-asthmatics, 48.3% would support a fragrance-
free workplace (compared with 21.0% that would not), and
among the general population, 53.1% would support a
fragrance-free workplace (compared with 19.7% that would
not). Thus, regardless of population, fragrance-free work-
places receive more than twice as many in support as not.
Asthmatics also strongly prefer fragrance-free airplanes
and hotels. If given a choice between flying on an airplane
that pumped scented air throughout the passenger cabin, or did
not pump scented air throughout the passenger cabin, 63.6%
Table 3 Demographic information for individuals reporting adverse effects from exposure to fragranced products
Asthmatics Non-asthmatics General population
N
% of column total
N
% of asthmatics
row, Table 1
N
% of column total
N
% of non-asthmatics
row, Table 1
N
% of column total
N
% of general
population
row, Table 1
Total 196 196 198 198 394 394
100.0% 64.3% 100.0% 23.8% 100.0% 34.7%
Male/female
All males 94 94 79 79 173 173
48.0% 69.1% 39.9% 20.3% 43.9% 33.0%
All females 102 102 119 119 221 221
52.0% 60.4% 60.1% 26.9% 56.1% 36.1%
Gender–age
Male 18–24 8 8 6 6 14 14
4.1% 50.0% 3.0% 19.4% 3.6% 29.8%
Male 25–34 30 30 17 17 47 47
15.3% 83.3% 8.6% 18.1% 11.9% 36.2%
Male 35–44 31 31 24 24 55 55
15.8% 73.8% 12.1% 25.5% 14.0% 40.4%
Male 45–54 17 17 15 15 32 32
8.7% 56.7% 7.6% 19.2% 8.1% 29.6%
Male 55–65 8 8 17 17 25 25
4.1% 66.7% 8.6% 18.5% 6.3% 24.0%
Female 18–24 12 12 8 8 20 20
6.1% 46.2% 4.0% 15.4% 5.1% 25.6%
Female 25–34 23 23 27 27 50 50
11.7% 57.5% 13.6% 28.4% 12.7% 37.0%
Female 35–44 28 28 33 33 61 61
14.3% 65.1% 16.7% 29.5% 15.5% 39.4%
Female 45–54 27 27 26 26 53 53
13.8% 65.9% 13.1% 25.2% 13.5% 36.8%
Female 55–65 12 12 25 25 37 37
6.1% 63.2% 12.6% 30.9% 9.4% 37.0%
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of asthmatics would choose an airplane without scented air
(compared to 24.9% with scented air). Similarly, if given a
choice between staying in a hotel with fragranced air, or with-
out fragranced air, 63.0% would choose a hotel without
fragranced air (compared to 28.5% with fragranced air).
Among non-asthmatics, 57.6 and 52.9% would prefer
fragrance-free airplanes and hotels, respectively (compared
with 23.1 and 27.5% that would not) and among the general
population, 59.2 and 55.6% would prefer fragrance-free air-
planes and hotels, respectively (compared with 23.6 and
27.8% that would not). Thus, overall, more than twice as
many asthmatics, as well as the general population, would
prefer that airplanes and hotels were fragrance-free rather than
fragranced.
Discussion
Asthma is a serious and increasing health condition, affecting
an estimated 25 million Americans, and costing an estimated
$56 billion annually in medical expenses, missed school and
work days, and premature deaths (CDCP 2017a). Nearly 12
million Americans had an asthma attack in 2015, many of
which could have been prevented (CDCP 2017b).
Results from this study show that asthmatics are pro-
foundly, adversely, and disproportionately affected by ex-
posure to fragranced consumer products. While non-
asthmatics are also affected, asthmatics are more likely to
experience adverse health effects from exposure (POR 5.76;
95% CI 4.34–7.64).
Of particular concern are involuntary exposures to
fragranced products, such as in health care facilities and work-
places. Asthmatics are prevented from accessing public toi-
lets, businesses, and workplaces due to adverse health effects
from fragranced products. Further, 35.4% have lost workdays
or a job, in the past year, due to fragranced product exposure in
the workplace. More than twice as many asthmatics would
prefer that workplaces, health care facilities, health care pro-
fessionals, airplanes, and hotels were fragrance-free than
fragranced.
Table 4 Frequency and types of health problems experienced by asthmatics, non-asthmatics, and the general population from exposure to four types of
fragranced consumer products
Air fresheners or deodorizers Scented laundry products Scented cleaning products Fragranced person
Asth Non-asth Gen Pop Asth Non-asth Gen Pop Asth Non-asth Gen Pop Asth Non-asth Gen Pop
Health problem 125 107 232 88 54 142 129 95 224 141 127 268
41.0% 12.9% 20.4% 28.9% 6.5% 12.5% 42.3% 11.4% 19.7% 46.2% 15.3% 23.6%
Migraines 46 36 82 24 13 37 42 33 75 45 51 96
36.8% 33.6% 35.3% 27.3% 24.1% 26.1% 32.6% 34.7% 33.5% 31.9% 40.2% 35.8%
Asthma attacks 49 4 53 27 1 28 42 4 46 41 3 44
39.2% 3.7% 22.8% 30.7% 1.9% 19.7% 32.6% 4.2% 20.5% 29.1% 2.4% 16.4%
Neurological 19 17 36 16 8 24 28 19 47 27 14 41
15.2% 15.9% 15.5% 18.2% 14.8% 16.9% 21.7% 20.0% 21.0% 19.1% 11.0% 15.3%
Respiratory 68 40 108 34 12 46 67 42 109 77 41 118
54.4% 37.4% 46.6% 38.6% 22.2% 32.4% 51.9% 44.2% 48.7% 54.6% 32.3% 44.0%
Skin 33 32 65 22 19 41 25 20 45 24 15 39
26.4% 29.9% 28.0% 25.0% 35.2% 28.9% 19.4% 21.1% 20.1% 17.0% 11.8% 14.6%
Cognitive 15 16 31 9 6 15 21 10 31 21 9 30
12.0% 15.0% 13.4% 10.2% 11.1% 10.6% 16.3% 10.5% 13.8% 14.9% 7.1% 11.2%
Mucosal 37 49 86 27 21 48 35 48 83 40 58 98
29.6% 45.8% 37.1% 30.7% 38.9% 33.8% 27.1% 50.5% 37.1% 28.4% 45.7% 36.6%
Immune system 16 5 21 16 3 19 18 5 23 17 2 19
12.8% 4.7% 9.1% 18.2% 5.6% 13.4% 14.0% 5.3% 10.3% 12.1% 1.6% 7.1%
Gastrointestinal 18 13 31 20 9 29 17 15 32 21 10 31
14.4% 12.1% 13.4% 22.7% 16.7% 20.4% 13.2% 15.8% 14.3% 14.9% 7.9% 11.6%
Cardiovascular 18 12 30 11 4 15 16 10 26 15 5 20
14.4% 11.2% 12.9% 12.5% 7.4% 10.6% 12.4% 10.5% 11.6% 10.6% 3.9% 7.5%
Musculoskeletal 19 8 27 21 2 23 13 10 23 15 2 17
15.2% 7.5% 11.6% 23.9% 3.7% 16.2% 10.1% 10.5% 10.3% 10.6% 1.6% 6.3%
Other 2 6 8 1 3 4 2 2 4 2 5 7
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Limitations of the study include the following: (a) data
were based on self-reports, although a well-established meth-
od for survey research; (b) all possible products and health
effects were not included, although the low percentages for
responses in the Bother^ category indicates the survey cap-
tured the primary products and effects; (c) product emissions
and exposures were not measured directly; (d) the cross-
sectional design of the study, while useful for determining
prevalence, provides data that represent just one point in time,
limiting the analysis of risk factors, temporal relationships
between exposures and effects, and trends in prevalence, and
(e) only adults (ages 18–65) were included in the survey,
which overlooks the effects of fragranced products on children
(such as in day care facilities and schools) and on seniors
(such as in retirement communities and assisted living
facilities).
Results of this study provide strong evidence that
fragranced consumer products can harm health for both asth-
matics and non-asthmatics, with asthmatics more affected.
Understanding why these products are associated with a range
of health problems is a critical topic that requires further re-
search. Fragranced products emit a range of volatile and semi-
volatile organic compounds, some of which are associated
with adverse health effects, but virtually none of which need
to be disclosed (Steinemann 2009, 2015), thus limiting scien-
tific inquiry and public awareness of potential exposures to
problematic compounds. A broader mechanistic framework is
needed to understand which ingredients, or combinations of
ingredients, could be associated with the adverse health out-
comes reported in this study. In the meantime, a prudent and
practical approach, and one that would provide direct and
immediate benefits, would be to limit exposure to fragranced
consumer products.
Acknowledgements I thank Amy Davis and John Barrie for their valu-
able assistance. I also thank the staff of Survey Sampling International for
their excellent work. This article is written as a tribute to my departed
colleague, Dr. Stanley Caress.
Compliance with ethical standards The research study received ethics
approval from the University of Melbourne.
Conflict of interest The author declares that she has no competing
interests.
Open Access This article is distributed under the terms of the Creative
Commons At t r ibut ion 4 .0 In te rna t ional License (h t tp : / /
creativecommons.org/licenses/by/4.0/), which permits unrestricted use,
distribution, and reproduction in any medium, provided you give
appropriate credit to the original author(s) and the source, provide a link
to the Creative Commons license, and indicate if changes were made.
References
Americans with Disabilities Act (ADA) (1990) Pub. L. No. 101–336, 104
Stat. 328
Caress SM, Steinemann AC (2009) Prevalence of fragrance sensitivity in
the American population. J Environ Health 71(7):46–50
Centers for Disease Control and Prevention (CDCP) (2017a) Asthma in
the US. https://www.cdc.gov/vitalsigns/asthma/index.html.
Accessed 12 Sept 2017
Centers for Disease Control and Prevention (CDCP) (2017b) Most
Recent Asthma Data. https://www.cdc.gov/asthma/most_recent_
data.htm. Accessed 12 Sept 2017
Elberling J, Linneberg A, Dirksen A, Johansen JD, Frølund L, Madsen F,
Nielsen NH, Mosbech H (2005) Mucosal symptoms elicited by
fragrance products in a population-based sample in relation to atopy
and bronchial hyper-reactivity. Clin Exp Allergy 35(1):75–81
Johansen JD (2003) Fragrance contact allergy: a clinical review. Am J
Clin Dermatol 4(11):789–798
Just AC, Adibi JJ, Rundle AG, Calafat AM, Camann DE, Hauser R, Silva
MJ,Whyatt RM (2010)Urinary and air phthalate concentrations and
self-reported use of personal care products among minority pregnant
women in NewYork city. J Expo Sci Environ Epidemiol 20(7):625–
633
Kelman L (2004) Osmophobia and taste abnormality in migraineurs: a
tertiary care study. Headache 44(10):1019–1023
Kumar P, Caradonna-GrahamVM, Gupta S, Cai X, Rao PN, Thompson J
(1995) Inhalation challenge effects of perfume scent strips in pa-
tients with asthma. Ann Allergy Asthma Immunol 75(5):429–433
Miller CS, Prihoda TJ (1999) The environmental exposure and sensitivity
inventory (EESI): a standardized approach for measuring chemical
intolerances for research and clinical applications. Toxicol Ind
Health 15(3–4):370–385
Millqvist E, Löwhagen O (1996) Placebo-controlled challenges with per-
fume in patients with asthma-like symptoms. Allergy 51(6):434–
439
Nazaroff WW, Weschler CJ (2004) Cleaning products and air fresheners:
exposure to primary and secondary air pollutants. Atmos Environ
38:2841–2865
Rastogi SC, Johansen JD, Bossi R (2007) Selected important fragrance
sensitizers in perfumes—current exposures. Contact Dermatitis
56(4):201–204
SSI (Survey Sampling International) (2016) Dynamix Sampling
Approach. Available from: https://www.surveysampling.com/
technology/ssi-dynamix/. Accessed 14 March 2017
Steinemann AC (2009) Fragranced consumer products and undisclosed
ingredients. Environ Impact Assess Rev 29(1):32–38
Steinemann A (2015) Volatile emissions from common consumer prod-
ucts. Air Qual Atmos Health 8(3):273–281
Steinemann A (2016) Fragranced consumer products: exposures and ef-
fects from emissions. Air Qual Atmos Health 9(8):861–866
Weinberg JL, Flattery J, Harrison R (2017) Fragrances and work-related
asthma–California surveillance data,1993-2012. J Asthma 23:1–10
Weschler CJ (2009) Changes in indoor pollutants since the 1950s. Atmos
Environ 43(1):156–172
Air Qual Atmos Health (2018) 11:3–9 9
